Log In Sign Up

Trading

Trading

Browse Companies

Data

Data

IPO Stock Tracker

Solutions

Solutions

For Institutions

For Shareholders

Insights

Insights

Popular Topics

Buying Pre-IPO Shares

Selling Pre-IPO Shares

Private Market Reports

Private Market Data & Analytics

About

About

Investor Relations

People & Culture

Inflammatix Stock

inflammatix.comHealthcareFounded: 2016Funding to Date: $160.26MM

Inflammatix uses molecular diagnostics to read the patient’s immune system to deliver rapid results that improve patient care and reduce major public health burdens.

Buy or sell Inflammatix stock Learn more about Inflammatix IPO

Overview Financings Valuation

Enterprise Value (based on primary financings)

Enterprise Value

View Enterprise Value for Inflammatix.

Register Today

Other companies like Inflammatix in the Healthcare sector

Sector

Last Round Est. Valuation

$2.15B

Colossal Biosciences

Sector

Sector

Last Round Est. Valuation

$3.67B

Sector

Last Round Est. Valuation

$400.53MM

Sector

Last Round Est. Valuation

$4.26B

Sector

Mammoth Biosciences

Sector

Last Round Est. Valuation

$1.08B

Sector

Precision Neuroscience

Sector

News

Genomeweb 11/18/2021

Inflammatix Receives Additional $12.1M BARDA Funding for MDx Acute Infection Test, System

The award represents the third tranche of funding from a test development contract worth up to $72 million if all options are exercised.

Frequently Asked Questions